Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
alzheimer's disease, Type 2 Diabetes
Ozempic May Be Linked to Lower Risk of Alzheimer’s in People with Type 2 Diabetes
According to a recent study, certain classes of weight loss drugs — including Ozempic — may have positive effects on the brain and patients with type 2 diabetes.
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in diabetes patients.
Can Semaglutide reduce the risk of Alzheimer’s? A new study offers hope of a therapy option
Semaglutide, the blood sugar control and weight loss drug, has another added benefit. A recent study, published in Alzheimer’s & Dementia, shows that it can reduce the risk of Alzheimer’s Disease in people with Type 2 diabetes.
technologynetworks
14h
Popular Diabetes and Weight-Loss Drug May Cut Alzheimer’s Disease Risk
Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, ...
Medical News Today
12h
Semaglutide drugs may help keep Alzheimer's at bay
People with type 2 diabetes who use semaglutide drugs like Ozempic and Wegovy appear to have a lower risk of Alzheimer's ...
Medscape
1d
Oral Semaglutide May Boost Liver Health in Type 2 Diabetes
Oral semaglutide improved liver health, diabetes status, and lipid profile in patients with MASLD and T2D, with weight loss ...
21h
Novo Nordisk's semaglutide could also be effective against Alzheimer's
A new study is adding to evidence that GLP-1 drugs such as Novo Nordisk's semaglutide and Eli Lilly's tirzepatide could also ...
Daily
3d
Oral semaglutide cuts MACE risk by 14% in adults with type 2 diabetes: SOUL trial
According to new data from the SOUL trial Oral semaglutide reduced MACE by 14% in Type 2 Diabetes patients. Novo Nordisk will ...
1d
on MSN
Ozempic linked to lower Alzheimer's risk in people with Type 2 diabetes
Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...
HealthDay on MSN
16h
Duodenal ReCET Plus Semaglutide Can Prevent Need for Insulin in T2DM
For patients with type 2 diabetes (T2D), duodenal recellularization via electroporation therapy (ReCET), which uses pulsed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback